Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Haematologica
; 109(1): 325-330, 2024 Jan 01.
Article
in En
| MEDLINE
| ID: mdl-37584289
Full text:
1
Database:
MEDLINE
Main subject:
Waldenstrom Macroglobulinemia
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2024
Type:
Article